AlphAIAlphAI — Financial news for AI agents
pehub.comOCT 61 min read

CD&R and McKesson ink $5.8bn take-private deal for Option Care Health

Private equity firm Clayton, Dubilier & Rice (CD&R) and McKesson have agreed to acquire Option Care Health in a $5.8bn take-private deal. Option Care Health operates in all 50 US states, employing over 8,000 staff, including 5,000 clinicians, providing home and alternate site infusion services.

Original reporting
pehub.com
Published Oct 6, 2026, 2:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 4:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CD&R and McKesson ink $5.8bn take-private deal for Option Care Health — source image
Source · pehub.com
Decision brief

The 30-second read

High
01

Why it matters

The transaction removes Option Care Health from public markets, delivering a premium to shareholders and expanding McKesson's service portfolio.

02

Market read

A major private‑equity acquisition in the healthcare sector, likely to influence valuation and M&A activity among peers.

03

What to watch

Potential integration challenges and reimbursement risks for the combined entity.

Relevance 9/10Novelty 9/10Timing: immediate

Background

CD&R and McKesson announced a $5.8 billion take‑private transaction for Option Care Health, a provider of home infusion services across the United States.

Market effects

Sector

Consolidation in home infusion services may pressure peers.

Regional

US healthcare M&A activity could see increased deal flow.

Global

Large private‑equity buyout signals continued appetite for healthcare assets worldwide.

Counterpoint

What could challenge this read

Deal could face regulatory scrutiny or financing hurdles, delaying closure.

Key entities

  • Company
    Option Care Health

    Home and alternate site infusion services provider.

  • Private Equity Firm
    CD&R

    Co‑investor in the take‑private deal.

  • Healthcare Distributor
    McKesson

    Co‑investor and strategic partner in the acquisition.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min
OCT 8
$MCKHighAI 9/10

McKesson & CD&R Acquire Leading US Home-Infusion Platform

McKesson and private equity firm CD&R will acquire Option Care Health, a US home-infusion care provider, for $5.8bn. CD&R will take a majority stake, while McKesson invests $1.4bn for a minority stake. The deal values Option Care Health at $32.05 per share and is expected to close in H1 2027. McKesson aims to leverage the acquisition to expand its specialty care offerings.

healthcare-digital.com3 min
OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min